Instil Bio Inc (TIL)
29.44
-2.10
(-6.66%)
USD |
NASDAQ |
Nov 14, 16:00
29.06
-0.38
(-1.29%)
After-Hours: 20:00
Instil Bio Cash and Short Term Investments (Quarterly): 148.61M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 148.61M |
| March 31, 2024 | 153.79M |
| December 31, 2023 | 150.36M |
| September 30, 2023 | 183.45M |
| June 30, 2023 | 201.70M |
| March 31, 2023 | 223.20M |
| December 31, 2022 | 260.92M |
| September 30, 2022 | 303.29M |
| Date | Value |
|---|---|
| June 30, 2022 | 354.61M |
| March 31, 2022 | 379.52M |
| December 31, 2021 | 454.10M |
| September 30, 2021 | 515.36M |
| June 30, 2021 | 566.72M |
| March 31, 2021 | 609.64M |
| December 31, 2020 | 241.71M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
148.61M
Minimum
Jun 2024
609.64M
Maximum
Mar 2021
316.46M
Average
260.92M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Merck & Co Inc | 14.59B |
| Elite Pharmaceuticals Inc | 8.407M |
| BioCardia Inc | 1.421M |
| Zevra Therapeutics Inc | 49.26M |
| NovaBay Pharmaceuticals Inc | 0.776M |